Skip to main content
Equibles
IBIO logo

IBIO · iBio, Inc.

Track IBIO — free

Use IBIO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about IBIO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.45 +0.02 (+1.05%)
Going-concern doubt — cleared May 12, 2026

The latest filing states the doubt was alleviated.

“The history of significant losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations in the past raised substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed May 12, 2026
Market Cap
$71.04M
Shares
49.68M

iBio, Inc. Earnings Call Transcripts

Every quarterly earnings call for iBio, Inc. (IBIO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲279.6% $410,000 −$7.53M '21 Q1 20-10-13 ▲124.5% $705,000 −$8.13M '21 Q2 21-02-16 ▲696.9% $765,000 −$7.66M '21 Q3 21-05-17 ▼56.2% $491,000 $116,000 '21 Q4 21-09-27 ▼79.5% $84,000 −$8.94M '22 Q1 21-11-15 ▼100% $ −$11.92M '22 Q2 22-02-14 ▲135.3% $1.80M −$12.39M '22 Q3 22-05-12 LATEST ▼100% $ −$17.05M '22 Q4 22-09-27
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY22 · Q4
2022-09-27
iBio, Inc. Q4 FY2022 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-05-12
iBio, Inc. Q3 FY2022 Earnings Call
Revenue
$1.80M
▲ 135.3% YoY
Diluted EPS
$-28.40
Gross margin
105.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-02-14
iBio, Inc. Q2 FY2022 Earnings Call
Revenue
$
▼ 100% YoY
Diluted EPS
$-27.40
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-11-15
iBio, Inc. Q1 FY2022 Earnings Call
Revenue
$84,000
▼ 79.5% YoY
Diluted EPS
$-48.00
Gross margin
203.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-09-27
iBio, Inc. Q4 FY2021 Earnings Call
Revenue
$491,000*
▼ 56.2% YoY
Gross margin
-32.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-05-17
iBio, Inc. Q3 FY2021 Earnings Call
Revenue
$765,000
▲ 696.9% YoY
Diluted EPS
$-20.00
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-02-16
iBio, Inc. Q2 FY2021 Earnings Call
Revenue
$705,000
▲ 124.5% YoY
Gross margin
70.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-10-13
iBio, Inc. Q1 FY2021 Earnings Call
Revenue
$410,000
▲ 279.6% YoY
Gross margin
73.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–9 of 9 earnings calls
Key facts CIK 1420720 CUSIP 451033708 13F (30d) 59 filings 56 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)